Does AMIVANTAMAB-VMJW Cause Ocular hyperaemia? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Ocular hyperaemia have been filed in association with AMIVANTAMAB-VMJW. This represents 0.4% of all adverse event reports for AMIVANTAMAB-VMJW.
8
Reports of Ocular hyperaemia with AMIVANTAMAB-VMJW
0.4%
of all AMIVANTAMAB-VMJW reports
0
Deaths
1
Hospitalizations
How Dangerous Is Ocular hyperaemia From AMIVANTAMAB-VMJW?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB-VMJW. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB-VMJW Cause?
Infusion related reaction (509)
Rash (315)
Off label use (130)
Dyspnoea (81)
Paronychia (78)
Nausea (65)
Oxygen saturation decreased (55)
Flushing (54)
Death (53)
Non-small cell lung cancer (51)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which AMIVANTAMAB-VMJW Alternatives Have Lower Ocular hyperaemia Risk?
AMIVANTAMAB-VMJW vs AMLODIPINE
AMIVANTAMAB-VMJW vs AMLODIPINE BESILATE
AMIVANTAMAB-VMJW vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB-VMJW vs AMLODIPINE\BENAZEPRIL
AMIVANTAMAB-VMJW vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN